STOCK TITAN

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Centessa Pharmaceuticals (Nasdaq: CNTA) announced participation in two upcoming investor conferences. The first is the Jefferies Healthcare Conference, scheduled for June 9, 2022, featuring a fireside chat webcast at 4:30 PM ET. The second is the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, with a fireside chat at 8:00 AM PT / 11:00 AM ET. Live webcasts and archived recordings will be accessible in the investor relations section of the Centessa website.

Positive
  • None.
Negative
  • None.

BOSTON and LONDON, June 06, 2022 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company with a Research & Development (“R&D”) innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients, today announced that Saurabh Saha, MD, PhD, Chief Executive Officer and Gregory Weinhoff, MD, Chief Financial Officer, will participate in the following investor conferences:

Event: Jefferies Healthcare Conference
Date: Thursday, June 9, 2022
Fireside Chat Webcast Time: 4:30 PM ET

Event: Goldman Sachs 43rd Annual Global Healthcare Conference
Date: Wednesday, June 15, 2022
Fireside Chat Webcast Time: 8:00 AM PT/ 11:00 AM ET

Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at Events & Presentations | Centessa Pharmaceuticals.

About Centessa Pharmaceuticals

Centessa Pharmaceuticals plc (“Centessa”) is a clinical-stage pharmaceutical company with a Research & Development (“R&D”) innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We are led by a management team with extensive R&D experience, providing direct guidance to our program teams to rapidly advance our candidates from research through all stages of development. For more information, visit www.centessa.com, which does not form part of this release.

Contact:

Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com


FAQ

When is Centessa Pharmaceuticals participating in the Jefferies Healthcare Conference?

Centessa Pharmaceuticals will participate in the Jefferies Healthcare Conference on June 9, 2022.

What time is the Centessa Pharmaceuticals webcast at the Jefferies Healthcare Conference?

The webcast for Centessa Pharmaceuticals at the Jefferies Healthcare Conference is scheduled for 4:30 PM ET.

When will Centessa Pharmaceuticals be at the Goldman Sachs Annual Global Healthcare Conference?

Centessa Pharmaceuticals is scheduled to participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022.

What time is the webcast for Centessa Pharmaceuticals at the Goldman Sachs Conference?

The webcast for Centessa Pharmaceuticals at the Goldman Sachs Conference will be at 8:00 AM PT / 11:00 AM ET.

Where can I find the webcasts of Centessa Pharmaceuticals' investor conferences?

The webcasts for Centessa Pharmaceuticals' investor conferences can be found on the 'Events and Publications' section of their investor relations website.

Centessa Pharmaceuticals plc American Depositary Shares

NASDAQ:CNTA

CNTA Rankings

CNTA Latest News

CNTA Stock Data

2.30B
114.15M
1.32%
92.52%
1.85%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
ALTRINCHAM, CHESHIRE